Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
ROCKVILLE, Maryland, March 02, 2018 -- The American Kidney Fund (AKF), the nation’s leading nonprofit working on behalf of the 30 million Americans living with kidney disease, today added five new members to its national board of trustees:
|
|||
- Michael W. Flood, managing director and head of private equity of Northleaf Capital Partners in Toronto
- Richard T. Miller, M.D., lead thoracic surgeon and physician-in-chief, Surgery Care Center at Southcoast Hospitals Group in New Bedford, Massachusetts
- Silas P. Norman, M.D., M.P.H., clinical associate professor of internal medicine, Division of Nephrology, University of Michigan Medical School in Ann Arbor
- Lisa A. Robin, chief advocacy officer for the Federation of State Medical Boards in Washington, DC
- Michael R. Vaughan, M.D., director of medical specialties, and practice chief of nephrology at Kaiser Permanente Washington in the Pacific Northwest.
Chaired by 35-year kidney transplant recipient Robert M. Tarola, CPA, CGMA, AKF’s independent, volunteer board is a group of individuals with a broad range of professional backgrounds and personal experiences with kidney disease.
“We are so pleased to welcome our new board members, whose diversity of experience promises to enrich the board’s work in setting AKF's strategic direction for the coming years and providing appropriate oversight to ensure that we have the plans and the resources in place to carry out our vital mission,” said Tarola.
The complete list of trustees and officers, along with their biographies, can be found on AKF’s website.
About the American Kidney Fund
As the nation’s leading nonprofit working on behalf of the 30 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling 1 in 5 U.S. dialysis patients to access lifesaving medical care, including dialysis and transplantation. AKF holds the highest ratings from the nation’s charity watchdog groups, including Charity Navigator, which includes AKF on its “top 10” list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cb44b379-118f-4782-8e0f-38c102a6b58b
Alice Andors American Kidney Fund 240-292-7053 [email protected]
